Edition:
Deutschland

Corbus Pharmaceuticals Holdings Inc (CRBP.OQ)

CRBP.OQ on NASDAQ Stock Exchange Global Market

1.02USD
19 Oct 2020
Change (% chg)

$-0.09 (-8.11%)
Prev Close
$1.11
Open
$1.11
Day's High
$1.11
Day's Low
$1.02
Volume
586,355
Avg. Vol
858,446
52-wk High
$9.78
52-wk Low
$1.02

About

Corbus Pharmaceuticals Holdings, Inc. is a Phase-III, clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company operates through developing and commercializing therapeutics to treat rare... (more)

Buy/Sell

Sell Hold Buy
2.86 Mean rating from 7 analysts

Overall

Beta: 1.81
Market Cap(Mil.): $90.70
Shares Outstanding(Mil.): 81.71
Dividend: --
Yield (%): --

BRIEF-Corbus: Topline Results From Systemic Sclerosis Study On Track For Summer 2020

* CORBUS PHARMACEUTICALS REPORTS LAST SUBJECT VISIT IN RESOLVE-1 PHASE 3 STUDY OF LENABASUM FOR TREATMENT OF SYSTEMIC SCLEROSIS

BRIEF-Corbus Pharma Reports Q1 Financial Results

* CORBUS PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND CORPORATE UPDATES

BRIEF-Corbus Have Entered Into Open Market Sale Agreement With Jefferies

* CORBUS PHARMACEUTICALS - HAVE ENTERED INTO OPEN MARKET SALE AGREEMENT WITH JEFFERIES LLC RELATING TO SHARES OF COMMON STOCK OFFERED BY THIS PROSPECTUS

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.08%
Rohstoffe -0.15%
Industrie -0.07%
Konjunktur abhängige Waren & Dienstleistungen -0.05%
Konjunktur unabhängige Waren & Dienstleistungen -0.11%
Finanzindustrie -0.05%
Pharma -0.02%
Technologie +0.00%

Nachrichten aus der Wirtschaft